Ingevity Corp buy BMO Capital Markets
Start price
10.12.25
/
50%
€46.50
Target price
10.12.26
€60.10
Performance (%)
38.71%
Price
09:46
?
Summary
This prediction is currently active. With a performance of 38.71% the BUY prediction by BMO_Capital_Markets is a big success. This prediction currently runs until 10.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | 0.000% | 0.000% |
| iShares Core DAX® | 0.300% | 4.701% |
| iShares Nasdaq 100 | 0.434% | 12.255% |
| iShares Nikkei 225® | 1.633% | 12.616% |
| iShares S&P 500 | 0.566% | 7.786% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $64.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat